In a press release the EMA
announced that it developed a framework to formalise,
structure and further develop interactions with the academic community in the context of the European
medicines regulatory network.
The framework’s overall
objectives are:
- raising awareness of the mandate and work of
the European medicines regulatory network to increase academia’s trust in and engagement with the regulatory system;
- fostering the translation of academic research
into novel methodologies and medicines which meet regulatory standards and
address needs of public and animal health;
- ensuring that the best scientific expertise and academic
research are available on time to support effective evidence generation,
regulatory advice and guidance, as well as decision-making in regulatory
processes;
- working with academia to develop regulatory science that
embraces scientific progress in medicines development without compromising patient safety, such
as for example, the use of novel endpoints or novel methodologies.
Further information can be found here
